Teleflex
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Teleflex sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Teleflex: 6 sponsored US clinical trials, 3 recruiting.
Teleflex sponsors 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Vascular Access Device, with 1 trials.
Upper-quartile sponsor footprint
Teleflex sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
NCT07258290
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT06779630
A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices
NCT06604039
AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study
NCT06364865
Vascular Positioning System G4 Algorithm ECG Data Collection for Model Training Study
NCT05702515
Observational Study of Complications Related to Use of Peripherally Inserted Central Catheters
NCT01578993
Therapeutic Areas
What is open in the Teleflex pipeline
3 recruiting of 6 indexed (50% open); 3 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Vascular Access Device (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Teleflex: open-pipeline peers nationwide
Peers matched on 6 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Teleflex sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 60 Degrees Pharmaceuticals · 50% recruiting · 4 trials
Related
What to do with this Teleflex page
6 registered trials is a research-attention snapshot, not an endorsement of Teleflex or any single study.
- 3 of Teleflex's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Vascular Access Device is the condition Teleflex studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Vascular Access Device trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Teleflex pipeline card: 6 registered trials from official public datasets.Report a data error.